Biggest News Aggregation in the World
📰 Mckesson News

Page 63 - Mckesson News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mckesson. Real-time updates on events, politics, business and more.

McKesson : OGSIVEO (nirogacestat) FDA Approved for Desmoid Tumors, Available at Biologics by McKesson -December 05, 2023 at 09:19 am EST

CARY, N.C., Dec. 5, 2023-Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by SpringWorks Therapeutics as a limited...
Claire Crye Us Oncology Research Specialty Pharmacy Solutions Specialty Solutions Drug Administration Springworks Therapeutics Inc

Octave Bioscience Announces New CEO, Board Chairman

By Healthcare Edge Editorial Staff Octave Bioscience, Inc. said Founder William Hagstrom will become Chairman of the Board, while Doug Biehn is the new President and CEO. Mr. Biehn has over 20 years of experience in healthcare, building and scaling growth businesses, the company, which treats neurodegenerative diseases, wrote in a statement. Before joining Octave, […]
United States Doug Biehn William Hagstrom Octave Bioscience Inc Locala Health Healthcare Edge Editorial
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Eqis Capital Management Inc. Reduces Stock Holdings in McKesson Co. (NYSE:MCK)

Eqis Capital Management Inc. decreased its position in McKesson Co. (NYSE:MCK – Free Report) by 28.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,316 shares of the company’s stock after selling 929 shares during the period. Eqis Capital Management Inc.’s […]
United States Brians Tyler Leannb Smith Credit Suisse Group Mckesson Corporation Securities Exchange Commission
Source: wkrb13.com

Eqis Capital Management Inc. Sells 929 Shares of McKesson Co. (NYSE:MCK)

Eqis Capital Management Inc. decreased its holdings in McKesson Co. (NYSE:MCK – Free Report) by 28.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,316 shares of the company’s stock after selling 929 shares during the period. Eqis Capital Management Inc.’s holdings in […]
United States Brians Tyler Leannb Smith Prescription Technology Solutions Rx Arao Wealth Creation Management Jpmorgan Chase Co

Telephone and Texting Compliance News: Litigation Update — Amerifactors Alive and Well in the Ninth Circuit; Trim v. Reward Zone's Aftershocks | Mintz - Technology, Communications & Media Viewpoints

Despite changes in technology, fax-based TCPA class actions and related jurisprudence continue to march on. And just last month, the US Court of Appeals for the Ninth Circuit issued a...
United States True Health Chiropractic Inc Communications Commission Mckesson Corp Commission Consumer Us Court

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science